These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 2252305)

  • 1. The central 5-HT1A receptors: pharmacological, biochemical, functional, and regulatory properties.
    Hamon M; Gozlan H; el Mestikawy S; Emerit MB; Bolaños F; Schechter L
    Ann N Y Acad Sci; 1990; 600():114-29; discussion 129-31. PubMed ID: 2252305
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-HT3 receptors.
    Tyers MB
    Ann N Y Acad Sci; 1990; 600():194-202; discussion 202-5. PubMed ID: 2252310
    [No Abstract]   [Full Text] [Related]  

  • 3. [Serotonin receptors (results of the pharmacological study)].
    Valeeva LA; Sergeev PV; Shimanovskiĭ NL
    Eksp Klin Farmakol; 1997; 60(6):57-61. PubMed ID: 9460603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 5-HT1A receptors and 5-HT1A-mediated responses: effect of treatments that modify serotonergic neurotransmission.
    Frazer A; Hensler JG
    Ann N Y Acad Sci; 1990; 600():460-74; discussion 474-5. PubMed ID: 2174665
    [No Abstract]   [Full Text] [Related]  

  • 5. Use of forskolin stimulated adenylate cyclase in rat hippocampus as a screen for compounds that act through 5-HT1A receptors.
    Cornfield LJ; Nelson DL; Monroe PJ; Taylor EW; Nikam SS
    Proc West Pharmacol Soc; 1988; 31():265-7. PubMed ID: 3211913
    [No Abstract]   [Full Text] [Related]  

  • 6. Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.
    Millan MJ; Rivet JM; Canton H; Le Marouille-Girardon S; Gobert A
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1364-76. PubMed ID: 8450471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin receptor and reuptake sites: pharmacologic significance.
    Gonzalez-Heydrich J; Peroutka SJ
    J Clin Psychiatry; 1990 Apr; 51 Suppl():5-12; discussion 13. PubMed ID: 2157701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. G-protein activation at 5-HT1A receptors by the 5-ht1F ligand LY334370 in guinea-pig brain sections and recombinant cell lines.
    Dupuis DS; Colpaert FC; Pauwels PJ
    Br J Pharmacol; 1998 May; 124(2):283-90. PubMed ID: 9641544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of 5-HT1A receptors in the consolidation of learning in cognitively impaired rats.
    Meneses A; Terrón JA; Hong E
    Ann N Y Acad Sci; 1998 Dec; 861():286-7. PubMed ID: 9928294
    [No Abstract]   [Full Text] [Related]  

  • 10. Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist.
    Caicoya AG; Beneytez ME; Delgado M; Manzanares J; López-Rodríguez ML; Benhamu B; Morcillo MJ; Pozo MA; Rubia FJ; Fuentes JA
    Pharmacology; 2001 May; 62(4):234-42. PubMed ID: 11360001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In the search for selective ligands of 5-HT5, 5-HT6 and 5-HT7 serotonin receptors.
    Wesołowska A
    Pol J Pharmacol; 2002; 54(4):327-41. PubMed ID: 12523486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT6 receptor ligands and their antipsychotic potential.
    Arnt J; Olsen CK
    Int Rev Neurobiol; 2011; 96():141-61. PubMed ID: 21329787
    [No Abstract]   [Full Text] [Related]  

  • 13. [The agonists of I-A serotoninergic receptors restore in rats behavior impaired by L-dihydroxyphenylalanine].
    Bondarenko NA; Bondarenko NA; Baran L; Klodzinska A
    Biull Eksp Biol Med; 1990 Dec; 110(12):627-8. PubMed ID: 2083366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple 5-HT receptors in passive avoidance: comparative studies of p-chloroamphetamine and 8-OH-DPAT.
    Misane I; Ogren SO
    Neuropsychopharmacology; 2000 Feb; 22(2):168-90. PubMed ID: 10649830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New discoveries on antidepressive treatment: serotonin is the key].
    Evenden J
    Lakartidningen; 1997 Sep; 94(38):3262-6. PubMed ID: 9379793
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of the amide fragment on 5-HT1A receptor activity of some analogs of MP 3022.
    Paluchowska MH; Charakchieva-Minol S; Tatarczyńska E; Kłodzińska A
    Pol J Pharmacol; 1999; 51(5):415-21. PubMed ID: 10817542
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of 5-HT1A receptor agonists and antagonists on canine cataplexy.
    Nishino S; Shelton J; Renaud A; Dement WC; Mignot E
    J Pharmacol Exp Ther; 1995 Mar; 272(3):1170-5. PubMed ID: 7891329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacology of the enantiomers of UH301: opposing interactions with 5-HT1A receptors.
    Hillver SE; Björk L; Höök BB; Cortizo L; Nordvall G; Johansson AM; Ertan A; Csöregh I; Johansson L; Lewander T; Hacksell U
    Chirality; 1996; 8(8):531-44. PubMed ID: 9025253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of central 5-HT receptors and their adaptive changes following intracerebral 5,7-dihydroxytryptamine administration in the rat.
    Nelson DL; Herbet A; Bourgoin S; Glowinski J; Hamon M
    Mol Pharmacol; 1978 Nov; 14(6):983-95. PubMed ID: 732817
    [No Abstract]   [Full Text] [Related]  

  • 20. Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies.
    Schechter LE; Bolaños FJ; Gozlan H; Lanfumey L; Haj-Dahmane S; Laporte AM; Fattaccini CM; Hamon M
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1335-47. PubMed ID: 1702155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.